« Previous | Next » | All Messages |  EFSF Message Board Home | recommend post |  Ignore Poster

EFSF News eFoodSafety.com, Inc. Prepares for National Launch of New Cholesterol Product into This Multi-Billion Dollar Market

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB:EFSF), a Company dedicated to improving health conditions around the world through innovative products and technologies, today announced that its cholesterol product, Cinnechol™, is ready for national retail distribution through the Company’s current and growing distribution channels.

The formulation and packaging of Cinnechol™ is complete and the Company is planning a national advertising campaign to introduce the product to the general public within the next 60 days.

Cinnechol™ is a new multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects while helping to decrease LDL (bad) cholesterol, lower triglycerides, and lower the LDL to HDL (good) cholesterol ratio.

Cinnechol™’s all natural ingredients work synergistically to decrease the viscosity, or thickness of the blood, which allows for better circulation. Additionally, the blend of nutrients in Cinnechol™ can assist in fighting inflammation, vital to the health of the heart and blood vessels. The ingredients in Cinnechol™ also can help increase levels of CoQ10, an essential enzyme needed for healthy heart muscle function.

Naturally treating cardiovascular disease (CVD) is essential as 1 in 5 Americans over the age of 20 have high cholesterol, a major factor contributing to CVD. Approximately 1.4 million people die annually in the US due to heart disease, the leading cause of death in this country since 1900. The annual national cost of all treatments for cardiovascular disease is close to $400 billion.

Patricia Gruden, President and CEO of eFoodSafety.com, Inc., stated, “We are excited to bring to market a treatment working to help control cholesterol, a major health risk in this country. We believe the important difference between Cinnechol™ and the products of major pharmaceutical companies is its effectiveness without any associated side effects.”

About eFoodSafety.com, Inc.

eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company’s Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) – EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company’s MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn™-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn™ line. The company is also owner of Cinnergen™, a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com). The company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect™ anti-acne skin care system.

Please visit the Company’s website at: http://www.efoodsafety.com.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly historical are “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties and the company’s actual results may differ from these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company’s products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.